胃肠道新陈代谢中的胆固醇机制
Natalia Sampaio Moura1, Alyssa Schledwitz1, Madeline Alizadeh2
1Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
International journal of molecular sciences
|May 25, 2024
概括
尼古丁性和肌肉性乙胆受体都与胃肠道癌症有关. 了解它们的作用可能会导致胃,胰腺和结肠腺癌的新预后和治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 由乙胆激活的受体存在于尼古丁和肌肉素亚型.
- 这两种受体类型都参与正常的消化功能.
- 胆固醇信号的失调与胃肠道瘤有关.
研究的目的:
- 审查乙胆受体的分类和功能.
- 检查胃肠道中乙胆的合成,释放和测量.
- 评估乙胆受体在促进胃肠道癌症中的作用.
主要方法:
- 关于乙胆受体分类和功能的文献综述.
- 在胃肠道微环境中对乙胆合成和释放机制的分析.
- 关键评价证据,将胆固醇信号与胃肠道瘤联系起来.
主要成果:
- 乙胆受体 (尼古丁性和肌肉性) 在正常的肠道功能中至关重要.
- 在准确测量乙胆水平方面存在挑战.
- 证据支持乙胆受体激活在促进胃,胰腺和结肠腺癌中的作用.
结论:
- 胆固醇信号通路与胃肠道癌症的发展有关.
- 向乙胆受体为新型癌症预后和治疗提供了潜力.
- 需要进一步的研究,以充分阐明这些机制的临床应用.
相关概念视频
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K
Parasympathetic Signaling
1.9K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
1.9K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
661
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
661
Cholinergic Antagonists: Pharmacological Actions
1.1K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.1K
Cholinergic Receptors: Muscarinic
2.1K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.1K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
731
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
731


